Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics
Cyclophosphamide mechanism of action on DNA showing the inter- and intrastrand crosslinks that cause DNA damage and trigger apoptosis in cancer cells (a) and its metabolic pathway showing its bioactivation from a prodrug to an active agent and its terminal cytotoxic metabolites (b)
Publication
Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics (2024) Ibrahim El-Serafi, et al. Adv Pharmacol Pharm Sci. 2024;2024(NA). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|